Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Trends in Biotechnology
|
May 14, 2026
Automated stem cell-derived organoid platforms for disease modeling
Xingrui Mou, Nathan Dale, Kiran Ramnarine, et al.
ACS Omega
|
August 29, 2019
Hydrophobic Cholesteryl Moieties Trigger Substrate Cell-Membrane Interaction of Elastin-Mimetic Protein Coatings in Vitro
Leander Poocza, Filippo Cipriani, Matilde Alonso, et al.
Blood Purification
|
August 30, 2014
Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT study
Matteo Ruggeri, Filippo Cipriani, Antonio Bellasi, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Claudio Jommi, Filippo Cipriani, Francesca Fanelli, et al.
Journal of Asthma and Allergy
|
July 29, 2021
Atopic Dermatitis and Patient Perspectives: Insights of Bullying at School and Career Discrimination at Work
Luca Stingeni, Anna Belloni Fortina, Ilaria Baiardini, et al.
Nature Cell Biology
|
September 21, 2010
Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation
Clare C Davies, Atanu Chakraborty, Filippo Cipriani, et al.
Journal of Nephrology
|
July 17, 2014
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
Matteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
La Radiologia Medica
|
February 21, 2015
Age estimation from canine volumes
Danilo De Angelis, Daniel Gaudio, Nicola Guercini, et al.
Journal of Nephrology
|
August 8, 2014
Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
Matteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
Italian Journal of Dermatology and Venereology
|
April 21, 2021
Dupilumab treatment induced similar improvements in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis with baseline Eczema Area and Severity Index Score <24 or ≥24
Annamaria Offidani, Luca Stingeni, Iria Neri, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Trends in Biotechnology
|
May 14, 2026
Automated stem cell-derived organoid platforms for disease modeling
Xingrui Mou, Nathan Dale, Kiran Ramnarine, et al.
ACS Omega
|
August 29, 2019
Hydrophobic Cholesteryl Moieties Trigger Substrate Cell-Membrane Interaction of Elastin-Mimetic Protein Coatings in Vitro
Leander Poocza, Filippo Cipriani, Matilde Alonso, et al.
Blood Purification
|
August 30, 2014
Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT study
Matteo Ruggeri, Filippo Cipriani, Antonio Bellasi, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Claudio Jommi, Filippo Cipriani, Francesca Fanelli, et al.
Journal of Asthma and Allergy
|
July 29, 2021
Atopic Dermatitis and Patient Perspectives: Insights of Bullying at School and Career Discrimination at Work
Luca Stingeni, Anna Belloni Fortina, Ilaria Baiardini, et al.
Nature Cell Biology
|
September 21, 2010
Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation
Clare C Davies, Atanu Chakraborty, Filippo Cipriani, et al.
Journal of Nephrology
|
July 17, 2014
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
Matteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
La Radiologia Medica
|
February 21, 2015
Age estimation from canine volumes
Danilo De Angelis, Daniel Gaudio, Nicola Guercini, et al.
Journal of Nephrology
|
August 8, 2014
Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
Matteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
Italian Journal of Dermatology and Venereology
|
April 21, 2021
Dupilumab treatment induced similar improvements in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis with baseline Eczema Area and Severity Index Score <24 or ≥24
Annamaria Offidani, Luca Stingeni, Iria Neri, et al.
Page
of 3